Începând de astăzi, Pacienții care se adresează colectivului de chirurgi ortopezi de la Spitalul Județean de Urgenta Târgu Mureș, pot beneficia de implanturile de cartilaj pentru rezolvarea defectelor articulare
Tratarea leziunilor de cartilaj folosind implanturile MaioRegen
To date, more than 4.000 patients have been treated with MaioRegen, which is considered an effective and safe treatment.
A randomized controlled clinical trial (RCT) vs. microfracture (Level of Evidence 1) shows a statistical significant improvement in the clinical scores (IKDC Subjective, Tegner, KOOS, VAS) at 2 years follow-up.
MaioRegen has proven to be superior to microfracture in the following indications: deep osteochondral lesions, osteochondritis dissecans (OCD) and in the population of sport active patients.
Deep Osteochondral Lesions (Outerbridge Grade IV)
Statistically significant superiority of MaioRegen vs. Microfracture (+12.4 points in change from baseline for IKDC subjective score).
Osteochondritis Dissecans (OCD)
Superiority of 12 points in change from baseline of MaioRegen vs. Microfracture in IKDC Subjective score.
Sport Active Patients
Statistically significant superiority of MaioRegen vs. Microfracture (+16 points in change from baseline for IKDC subjective score).
Superiority of MaioRegen treatment in these populations provides clear indications for the treatment of osteochondral lesions with MaioRegen Prime.
Moreover, a pilot study with 27 patients shows the stability of clinical scores at 8 year of follow-up, in patients suffering from complex lesions treated with MaioRegen
Subjective IKDCX – 96 months follow-up
Tegner Score – 96 months follow-up
